Ponatinib in the leukemia world: why a reevaluation is necessary for Philadelphia chromosome-positive patients with T315I mutation.
about
Ponatinib in the leukemia world: why a reevaluation is necessary for Philadelphia chromosome-positive patients with T315I mutation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Ponatinib in the leukemia worl ...... patients with T315I mutation.
@en
Ponatinib in the leukemia worl ...... patients with T315I mutation.
@nl
type
label
Ponatinib in the leukemia worl ...... patients with T315I mutation.
@en
Ponatinib in the leukemia worl ...... patients with T315I mutation.
@nl
prefLabel
Ponatinib in the leukemia worl ...... patients with T315I mutation.
@en
Ponatinib in the leukemia worl ...... patients with T315I mutation.
@nl
P2860
P1476
Ponatinib in the leukemia worl ...... patients with T315I mutation.
@en
P2860
P304
P356
10.1586/17474086.2014.958465
P577
2014-09-09T00:00:00Z